
Sign up to save your podcasts
Or
STAT's FDA reporter Lizzy Lawrence joins us to discuss her profile of Marty Makary, Trump's nominee for FDA commissioner. Then, we discuss the results of Vertex's latest pain drug trial, the medication launches to watch in 2025, and present our burning questions for the biopharma industry.
4.5
304304 ratings
STAT's FDA reporter Lizzy Lawrence joins us to discuss her profile of Marty Makary, Trump's nominee for FDA commissioner. Then, we discuss the results of Vertex's latest pain drug trial, the medication launches to watch in 2025, and present our burning questions for the biopharma industry.
30,845 Listeners
1,040 Listeners
1,789 Listeners
478 Listeners
122 Listeners
84 Listeners
5,942 Listeners
391 Listeners
59 Listeners
29 Listeners
5,462 Listeners
147 Listeners
18 Listeners
51 Listeners
371 Listeners